Dr. Overman on Remaining Questions With Immunotherapy in CRC – OncLive
OncLive |
Dr. Overman on Remaining Questions With Immunotherapy in CRC
OncLive Michael J. Overman, MD, associate professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses the remaining questions with immunotherapy in colorectal cancer (CRC). The updated findings from … |
